B. Riley Wealth Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $256K | Buy |
6,158
+929
| +18% | +$38.6K | 0.01% | 938 |
|
2024
Q3 | $345K | Sell |
5,229
-888
| -15% | -$58.5K | 0.01% | 891 |
|
2024
Q2 | $726K | Sell |
6,117
-3,754
| -38% | -$446K | 0.02% | 654 |
|
2024
Q1 | $1.02M | Buy |
9,871
+1,549
| +19% | +$160K | 0.03% | 518 |
|
2023
Q4 | $828K | Sell |
8,322
-1,549
| -16% | -$154K | 0.02% | 591 |
|
2023
Q3 | $1.02M | Buy |
9,871
+1,616
| +20% | +$167K | 0.03% | 518 |
|
2023
Q2 | $1M | Buy |
8,255
+676
| +9% | +$82.1K | 0.02% | 565 |
|
2023
Q1 | $1.16M | Sell |
7,579
-2,503
| -25% | -$384K | 0.03% | 496 |
|
2022
Q4 | $1.81M | Buy |
10,082
+478
| +5% | +$85.9K | 0.05% | 364 |
|
2022
Q3 | $1.14M | Buy |
9,604
+2,675
| +39% | +$316K | 0.03% | 469 |
|
2022
Q2 | $990K | Buy |
6,929
+341
| +5% | +$48.7K | 0.04% | 425 |
|
2022
Q1 | $1.14M | Sell |
6,588
-2,636
| -29% | -$455K | 0.04% | 446 |
|
2021
Q4 | $2.34M | Sell |
9,224
-1,683
| -15% | -$428K | 0.07% | 314 |
|
2021
Q3 | $4.11M | Sell |
10,907
-9,293
| -46% | -$3.5M | 0.13% | 168 |
|
2021
Q2 | $4.69M | Sell |
20,200
-8,739
| -30% | -$2.03M | 0.15% | 158 |
|
2021
Q1 | $3.78M | Buy |
28,939
+3,206
| +12% | +$418K | 0.13% | 175 |
|
2020
Q4 | $2.69M | Buy |
25,733
+10,850
| +73% | +$1.13M | 0.14% | 161 |
|
2020
Q3 | $1.05M | Buy |
14,883
+3,998
| +37% | +$283K | 0.06% | 302 |
|
2020
Q2 | $699K | Buy |
+10,885
| New | +$699K | 0.05% | 356 |
|